Covance

CRO Cetero appoints James Dixon as SVP

Tuesday, April 26, 2011 02:07 PM

North Carolina-based CRO Cetero Research has appointed James "Jay" Dixon to senior vice president, quality and compliance. Dixon has spent more than 25 years in the pharmaceutical, biotechnology and CRO industries.  

More... »

Large SMOs Synexus and Radiant head to India seeking large pool of treatment-naïve patients

Monday, January 24, 2011 12:02 PM

Two large site management organizations (SMOs), Radiant Research and Synexus, are planning expansions into India.

More... »

More big pharmaceuticals join trend of partnering with CROs to cut costs, speed drug development

Monday, October 11, 2010 10:27 AM

Major pharmaceutical companies are increasingly forming long-term, strategic partnerships with a small number of global contract research organizations (CROs) in order to cut costs and streamline their outsourced clinical work.

More... »

Covance and Sanofi-aventis ink landmark 10-year, $2.2 billion R&D outsourcing partnership

Monday, October 4, 2010 10:01 AM

Hailed as the largest outsourcing partnership between a contract research organization (CRO) and a pharmaceutical company, Covance and Sanofi-aventis have signed a 10-year agreement in which the CRO will provide France’s largest pharmaceutical company with a wide range of research and drug development services, and receive between $1.2 billion and $2.2 billion in revenue.

More... »

Covance and Sanofi-Aventis sign 10-year, $2.2 billion strategic R&D alliance

Thursday, September 30, 2010 09:52 AM

CRO Covance, based in Princeton, N.J., today announced the signing of definitive agreements with Sanofi-aventis for a research and development partnership worth up to $2.2 billion.

More... »

Covance Opens Biorepository in Indiana

Thursday, June 24, 2010 08:51 AM

Covance, a global contract research organization (CRO), has opened a state-of-the-art biorepository facility at its Greenfield, Ind. location.

More... »

CenterWatch Monthly June 2010

Thursday, June 3, 2010 08:38 AM

i3 Research, PPD, Kendle, Covance Rated Top CROs in Europe in 2010

More... »

Firecrest Clinical Appoints New CEO

Thursday, May 20, 2010 09:06 AM

Firecrest Clinical, an eClinical solution provider, announces the appointment of Alan Horgan as CEO.

More... »

Covance Launches Discovery and Translational Services Division

Monday, May 17, 2010 12:59 PM

Covance has reorganized its early-stage drug development work into a new division dedicated to discovery services, antibody products and immunology. The new group, Discovery and Translational Services, integrates the CRO’s Biomarker Center for Excellence, formed in 2009, with its Genomics Laboratory and existing partnerships with Caprion Proteomics and Rules-Based Medicine. 

More... »

Covance Profits Down 3% in Q1 as Central Lab Division Suffers Project Delays

Thursday, April 29, 2010 08:09 AM

Covance’s revenues grew and income fell in the first quarter of 2010. The company’s first quarter net revenues were $481.9 million, a 9.2% increase over the same period last year. Net income for the quarter fell 2.9% to $39.1 million, or $0.60 diluted EPS, compared with $40.3 million, or $0.63 diluted EPS, in Q1 2009.

More... »